Display Settings:

Format

Send to:

Choose Destination
    Clin Rheumatol. 2010 Oct;29(10):1201-4. Epub 2010 Apr 26.

    Cerebral tuberculoma in a patient receiving anti-TNF alpha (adalimumab) treatment.

    Source

    Department of Neuropathology, Beaumont Hospital, Beaumont, Dublin 9, Ireland. karenlynch81@gmail.com

    Abstract

    We report a case of a cerebral tuberculoma in a 60-year-old woman with rheumatoid arthritis while receiving the anti-tumor necrosis factor alpha monoclonal antibody, adalimumab (Humira), for active disease. MR brain imaging for dyspraxia revealed a left parietal ring-enhancing lesion, which on resection was shown to be a necrotizing granuloma. There were no associated pulmonary lesions, and the patient was systemically well. Sputum and urine cultures were negative for tuberculosis. The patient was treated with anti-tuberculous medications and made an excellent recovery. We consider this to be the first documented case of tuberculosis involving the central nervous system occurring in the setting of adalimumab treatment.

    PMID:
    20419463
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Springer

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk